Literature DB >> 10833482

Inhibition of gastric mucin synthesis by Helicobacter pylori.

J C Byrd1, C K Yunker, Q S Xu, L R Sternberg, R S Bresalier.   

Abstract

BACKGROUND & AIMS: Mucins are high-molecular-weight glycoproteins that protect the gastric epithelium. Previous data suggested that gastric surface-type mucin is decreased in Helicobacter pylori-infected patients and restored after eradication of the infection. Our aim was to determine the effect of H. pylori on mucin synthesis in cultured gastric epithelial cells.
METHODS: Mucin synthesis was measured by labeling with [(3)H]glucosamine and size-exclusion chromatography. Expression of MUC5AC and MUC1 mucin protein antigens was quantitated by Western blot analysis.
RESULTS: Mucin synthesis was inhibited more than 80% when KATO III cells were incubated with H. pylori, with no effect on mucin secretion or degradation. Inhibition was rapid (4 hours), partially reversible, dependent on concentration of bacteria, and associated with the insoluble membrane fraction. H. pylori decreased levels of MUC5AC and MUC1 mucins. MUC1 inhibition was half-maximal by 4 hours and partially reversed by 24 hours, but the decrease in MUC5AC was less rapid and not reversible within 24 hours.
CONCLUSIONS: H. pylori inhibits total mucin synthesis in vitro and decreases the expression of MUC5AC and MUC1. A decrease in gastric mucin synthesis in vivo may disrupt the protective surface mucin layer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833482     DOI: 10.1016/s0016-5085(00)70360-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

1.  Alterations in gastric mucin synthesis by Helicobacter pylori.

Authors:  James C Byrd; Robert S Bresalier
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins.

Authors:  Samuel B Ho; Kenji Takamura; Ruth Anway; Laurie L Shekels; Neil W Toribara; Hiroyoshi Ota
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

Review 3.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

4.  Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.

Authors:  Mônica A M Vieira; Tânia A T Gomes; Antonio J P Ferreira; Terezinha Knöbl; Alain L Servin; Vanessa Liévin-Le Moal
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

5.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

6.  MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.

Authors:  Huachuan Zheng; Hiroyuki Takahashi; Takahiko Nakajima; Yoshihiro Murai; Zhengguo Cui; Kazuhiro Nomoto; Koichi Tsuneyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-29       Impact factor: 4.553

7.  Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.

Authors:  Wei Guang; Hua Ding; Steven J Czinn; K Chul Kim; Thomas G Blanchard; Erik P Lillehoj
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

8.  Transfection of the Helicobacter pylori CagA gene alters MUC5AC expression in human gastric cancer cells.

Authors:  Ding Shi; Yongpan Liu; Dong Wu; Xujun Hu
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

Review 9.  Probiotics for the treatment of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; John Frederick Osborn; Enea Bonci; Sara Romaggioli; Rossella Baldini; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy.

Authors:  Sara K Lindén; Yong H Sheng; Alison L Every; Kim M Miles; Emma C Skoog; Timothy H J Florin; Philip Sutton; Michael A McGuckin
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.